Jian Liu
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 34
- MicroRNA in disease regulation 13
- Molecular Biology top 1%
- RNA modifications and cancer 24
- RNA Research and Splicing 16
- Ubiquitin and proteasome pathways 14
- Immunology top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways 13
-
- Autophagy in Disease and Therapy 13
-
- Genetic Mapping and Diversity in Plants and Animals 10
- Co-authors
- Anton MestekLei YuAmanda HurleyYan ChenYuquan WeiXiawei WeiDandan WanManni Wang
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jian Liu
341 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Cancer Research 1.2k
- Molecular Biology 4.4k
- Cellular and Molecular Neuroscience 1.0k
- Immunology 996
- Oncology 1.1k
Countries citing papers authored by Jian Liu
This map shows the geographic impact of Jian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Liu more than expected).
Fields of papers citing papers by Jian Liu
This network shows the impact of papers produced by Jian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Liu. The network helps show where Jian Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jian Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 34 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 22 | |
| 16 | 2021 | 34 | |
| 17 | 2019 | 22 | |
| 18 | 2019 | 10 | |
| 19 | 2018 | 28 | |
| 20 | 1999 | 34 |
About Jian Liu
Jian Liu is a scholar working on Cancer Research, Physical Therapy, Sports Therapy and Rehabilitation and Molecular Biology, having authored 358 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (34 papers), RNA modifications and cancer (24 papers), RNA Research and Splicing (16 papers), Ubiquitin and proteasome pathways (14 papers), Cancer-related Molecular Pathways (13 papers), MicroRNA in disease regulation (13 papers), Autophagy in Disease and Therapy (13 papers) and Genetic Mapping and Diversity in Plants and Animals (10 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (4.4k citations) and Cellular and Molecular Neuroscience (1.0k citations). Jian Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Anton Mestek, Lei Yu, Amanda Hurley, Yan Chen, Yuquan Wei, Xiawei Wei, Dandan Wan, Manni Wang, Minyang Fu and Thurmon E. Lockhart. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.